Purpose of the Procedure
- Confirm the diagnosis of chronic myeloproliferative disorders.
- Distinguish between primary and secondary blood cell elevations.
- Provide prognostic information regarding disease progression.
Book MPN Molecular Panel in Saudi Arabia | Lahalak Medical Platform
Gain precise diagnostic insights into myeloproliferative neoplasms with our advanced molecular panel. Detecting key driver mutations ensures accurate classification and personalized treatment planning for optimal patient care outcomes.
Scientific name: Myeloproliferative Neoplasms (MPN) Molecular Panel
An advanced molecular test identifying driver mutations in JAK2, CALR, and MPL genes. It is essential for diagnosing polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Blood Collection
- JAK2 Mutation Analysis
- CALR Mutation Analysis
- MPL Mutation Analysis
Medical Service Information
Target Groups
- Patients suspected of having Polycythemia Vera.
- Individuals with unexplained high platelet counts (Essential Thrombocythemia).
- Patients showing signs of Bone Marrow Fibrosis.
Clinical Significance
- Guides the selection of appropriate biological or chemotherapy protocols.
- Offers precise data on the risk of disease transformation.
- Aids in monitoring the effectiveness of the treatment plan.
Conditions & Notices
- No special preparation required
- Previous medical reports are recommended
Medical services you might also like
